Lactobacillus casei and Bifidobacterium lactis supplementation reduces tissue damage of intestinal mucosa and liver after 2,4,6-trinitrobenzenesulfonic acid treatment in mice

Journal of Biological Regulators and Homeostatic Agents

Volumn 28, Issue 2, 2014, Pages 251-261

  Bellavia, M ^a   Rappa, F ^a,b   Bello, M L O ^b   Brecchia, G ^c   Tomasello, G ^a,b   Leone, A ^b   Spatola, G ^b   Uzzo, M L ^b   Bonaventura, G ^b   David, S ^b   Damiani, P ^b   Hajj Hussein, I ^d   Zeenny, M N ^b,e   Jurjus, A ^e   Schembri Wismayer, P ^f   Cocchi, M ^g,h   Zummo, G ^b   Farina, F ^b   Gerbino, A ^b   Cappello, F ^a,b,f   Traina, G ^c   more..

^a Euro Mediterranean Institute of Science and Technology   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

^c UNIVERSITY OF PERUGIA   (Italy)

^d OAKLAND UNIVERSITY WILLIAM BEAUMONT SCHOOL OF MEDICINE   (United States)

^e AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^f UNIVERSITY OF MALTA   (Malta)

^g Department of Veterinary Medical Sciences   (Switzerland)

^h UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Apoptosis; Intestinal cancer; Intestinal inflammation; Large bowel; Liver; Microbiota; Probiotic supplementation

Indexed keywords

ANIMALS; BIFIDOBACTERIUM; DIETARY SUPPLEMENTS; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; LACTOBACILLUS CASEI; LIVER; MALE; MICE; PROBIOTICS; TRINITROBENZENESULFONIC ACID;

EID: 84905646706     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Guarner F, Malagelada JR. Bacterial flora of the digestive tract. Gastroenterol Hepatol 2003; 26:1-5.
2. Kagnoff MF, Eckmann L. Epithelial cells as sensor for microbial infection. J Clin Invest 1997; 100:6-10. (Pubitemid 27311236)
3. Takeda K, Suzuki T, Shimada SI, et al. Interleukin-12 is involved in the enhancement of human natural killer cell activity by Lactobacillus casei Shirota. Clin Exp Immunol 2006; 146:109-15. (Pubitemid 44393845)
4. Drisko JA, Giles CK, Bischoff BJ Probiotics in health maintenance and disease prevention. Altern Med Rev 2003; 8:153-55.
5. Saavedra JM, Bauman NA, Oung I, Perman JA, Yolken RH. Feeding of Bifidobacterium bifidum and streptococcus thermophiles to infants in hospital for prevention of diarrhea and shedding of rotavirus. Lancet 1994; 344:1046-49. (Pubitemid 24310035)
6. Caplan MS, Jilling T. Neonatal necrotizing enterocolitis: possible role of probiotic supplementation. J Pediatr Gastroenterol Nutr 2000; 30:18-22.
7. Gorbach SL, Chang TW, Goldin B. Successful treatment of relapsing Clostridium difficile colitis with Lactobacillus GG. Lancet 1987; 2:1519. (Pubitemid 18013761)
8. Vanderhoof JA, Young RJ. Use of probiotics in childhood gastrointestinal disorders. J Pediatr Gastroenterol Nutr 1998; 27:323-32. (Pubitemid 28430865)
9. Aiba Y, Suzuki N, Kabir AM, Takagi A, Koga Y. Lactic acid-mediated suppression of Helicobacter pylori by the oral administration of Lactobacillus salivarius as a probiotic in a gnotobiotic murine model. Am J Gastroenterol 1998; 93:2097-101. (Pubitemid 29076857)
10. Gupta V, Garg R. Probiotics. Indian J Med Microbiol 2009; 27:202-9.
11. Sanders ME, Klaenhammer TR. Invited review: the scientific basis of Lactobacillus acidophilus NCFM functionality as a probiotic. J Dairy Sci 2001; 84:319-31.
12. Resta-Lenert SC, Barrett KE. Modulation of intestinal barrier properties by probiotics: role in reversing colitis molecular structure and function of the tight junction: Ann NY Acad Sci 2009; 1165:175-82.
13. Rachmilewitz D, Katakura K, Karmeli F, et al. Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology 2004; 126:520-28. (Pubitemid 38182309)
14. Neish AS, Gewirtz AT, Zeng H, et al. Prokaryotic regulation of epithelial responses by inhibition of IkBa degradation. Science 2000; 289:1560-63.
15. Otte JM, Podolsky DK. Functional modulation of enterocytes by grampositive and gram-negative microorganisms. Am J Physiol Gastrointest Liver Physiol 2004; 286:G613-26. (Pubitemid 38374981)
16. Maroof H, Hassan ZM, Mobarez AM, Mohamadabadi MA. Lactobacillus acidophilus could modulate the immune response against breast cancer in murine model. J Clin Inmmunol 2012; 32:1353-59.
17. Ma EL, Choi J, Pothoulakis C, Rhee SH, Im E. The anticancer effect of probiotic Bacillus polyfermenticus on human colon cancer cell is mediated through ErbB2 and ErbB3 inhibition. Int J Cancer 2010; 127:780-90.
18. Lan A, Lagadie-Gossmann D, Lemaire C, Brenner C, Jan G. Acidic extracellular pH shifts colo-rectal cancer cell death from apoptosis to necrosis upon exposure to propionate and acetate, major end-products of the human probiotic proprioni-bacteria. Apoptosis 2007; 12:573-91.
19. Jan G, Belzacq AS, Haouzi D, et al. Propionibacteria induce apoptosis of colorectal carcinoma cells via short-chain fatty acids acting on mitochondria. Cell Death Differ 2002; 9:179-88. (Pubitemid 34144777)
20. De Moreno LA, Perdigon G. The application of probiotic fermented milks in cancer and intestinal inflammation. Proc Nutr Soc 2010; 69:421-28.
21. Bassaganya-Riera J, Viladomiu M, Pedragosa M, De Simone C, Hontecillas R. Immunoregulatory mechanisms underlying prevention of colitis-associated colorectal cancer by probioticbacteria. PLoS ONE 2012; 7:e34676.
22. Morris G, Beck P, Herridge M, et al. Hapten-induced model of colonic inflammation and ulceration in the rat colon. Gastroenterology 1989; 96:795-803. (Pubitemid 19057602)
23. Scheiffele F, Fuss IJ. Induction of TNBS Colitis in Mice. Curr Protocol Immunol 2002; Chapter 15: Unit 15.19. doi: 10.1002/0471142735.
24. Tomasello G, Rodolico V, Zerilli M, et al. Changes in immunohistochemical levels and subcellular localization after therapy and correlation and colocalization with CD68 suggest a pathogenetic role of Hsp60 in ulcerative colitis. Appl Immunohistochem Mol Morphol 2011; 19:552-61.
25. Peran L, Camuesco D, Comalada M, et al. Preventative effects of a probiotic, Lactobacillus salivarius ssp. salivarius, in the TNBS model of rat colitis. World J Gastroenterol 2005; 11:5185-92. (Pubitemid 41410337)
26. Tang D, Lotze MT, Kang R, Zeh HJ. Apoptosis promotes early tumorigenesis. Oncogene 2011; 30:1851-4.
27. Cappello F, Bellafiore M, Palma A, Bucchieri F. Defective apoptosis and tumorigenesis: role of p53 mutation and Fas/FasL system dysregulation. Eur J Histochem 2002; 46:199-208. (Pubitemid 36612670)
28. Renehan AG, Bach SP, Potten CS. The relevance of apoptosis for cellular homeostasis and tumorigenesis in the intestine. Can J Gastroenterol 2001; 15:166-76. (Pubitemid 32899121)
29. Bellavia M, Tomasello G, Romeo M, et al. Gut microbiota imbalance and chaperoning system malfunction are central to ulcerative colitis pathogenesis and can be counteracted with specifically designed probiotics: a working hypothesis. Med Microbiol Immunol 2013; 202:393-406.
30. Sinagra E, Tomasello G, Cappello F, et al. Probiotics, probiotics and symbiotics in inflammatory bowel diseases: state-of-the-art and new insights. J Biol Regul Homeost Agents 2013; 27:919-33.
31. Bellavia M, Damiano G, Gioviale MC, et al. Abnormal expansion of segmented filamentous bacteria in the gut: a role in pathogenesis of chronic inflammatory intestinal diseases? Rev Med Microbiol 2011; 22:45-47.
32. Llopis M, Antolin M, Carol M, et al. Lactobacillus casei downregulates commensals inflammatory signals in Crohn's disease mucosa. Inflamm Bowel Dis 2009; 15:275-83.
33. Dominici L, Moretti M, Villarini M, et al. In vivo antigenotoxic properties of a commercial probiotic supplement containing Bifidobacteria. Int J Probiotics Prebiotics 2011; 6: 179-86.
34. Persichetti E, De Michele A, Codini M, Traina G. Antioxidative capacity of Lactobacillus fermentum evaluated in vitro by oxygen radical absorbance capacity assay. Nutrition 2014; in press; doi.org/10.1016/j.nut.2013.12.009.
35. Chong ES. A potential role of probiotics in colorectal cancer prevention: review of possible mechanisms of action. World J Microbiol Biotechnol 2014; 30:351-74.